SOURCE: Triplefin


March 25, 2014 10:14 ET

Triplefin Opens New Call Center to Manage Its Patient Assistance and Reimbursement Services

CINCINNATI, OH--(Marketwired - Mar 25, 2014) - Triplefin, a member of the H. D. Smith family of companies, will open a new reimbursement services call center in Fairfield, Ohio. The Fairfield location serves as an extension of its main office in Blue Ash.

Triplefin's new call center will employ a team of customer service representatives who are equipped to assist patients and providers with questions regarding access to medication, and coupon and co-pay card activation.

"We are excited about the new expansion for Triplefin with the Fairfield facility. It positions us for further growth to provide the highest level of service to our clients," commented Michael Hendrickson, director of Hub Services.

The new facility in Fairfield offers an efficient work environment along with advanced technology to help provide consistent, reliable service for Triplefin's clients, patients and providers. Real-time digital monitors offer a platform to communicate key call metrics, agent queue status and company news.

An open house for company associates will take place at the new Fairfield location on March 26, 2014.

About Triplefin

Triplefin, headquartered in Cincinnati, Ohio, is operating as a wholly owned subsidiary of H. D. Smith. A leading pharmaceutical brand support company for 33 years, Triplefin removes barriers to patient access and adherence with innovative products and services. Together with H. D. Smith, Triplefin provides an end-to-end solution that includes the Rx365™ Suite of Digital Solutions (benefit verification and prior authorization), patient assistance, patient reimbursement and patient adherence programs, co-pay and voucher solutions, sample fulfillment and sampling solutions, pharmacy services, third party logistics and National Specialty Pharmacy Nursing Network (SPNN).

Today, more than 50 pharmaceutical manufacturing companies (including 11 of the top 15), representing more than 150 brands across multiple therapeutic categories, partner with Triplefin to create strategic programs for patient access. Please visit